JTH: New Data Exposes Wide Variation in U.S. Perioperative Bleeding Management
Journal of Thrombosis and Haemostasis (JTH) posted on LinkedIn:
”Perioperative use of factor concentrates and blood products – a survey of clinical practices in the United States
By Jerrold Levy, Joseph R. Shaw, Kamrouz Ghadimi, Cheryl Maier, Douketis James, Keyvan Karkouti, Michael Mazzeffi, Alex C Spyropoulos, MD, FACP, FCCP, FRCPC, Kenichi Tanaka, Jean Connors, and Roman Sniecinski
The management of perioperative bleeding and anticoagulant reversal is rapidly evolving, shaped by new education initiatives and expanding availability of factor concentrates.
4-factor PCCs were the preferred therapy for warfarin and DOAC reversal in emergency surgery and major bleeding (used by >70%).
Cryoprecipitate remained the dominant source of fibrinogen replacement (66%), while access to fibrinogen concentrate was limited.
FFP continued as the first-line product for factor replacement in cardiac (60%), hepatic (67%), and postpartum hemorrhage (71%).
These data show a steady shift toward PCC-centric reversal strategies, with persistent heterogeneity in fibrinogen replacement and factor support across US perioperative settings.
Read the article here.”
Title: Perioperative use of factor concentrates and blood products—a survey of clinical practices in the United States: communication from the ISTH Subcommittee on Perioperative and Critical Care
Authors: Jerrold H. Levy, Joseph R. Shaw, Kamrouz Ghadimi, Cheryl L. Maier, James Douketis, Keyvan Karkouti, Michael Mazzeffi, Alex C. Spyropoulos, Kenichi A. Tanaka, Jean M. Connors, Roman M. Sniecinski
Stay updated with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?